HomeAI · summaries
Storia in 3 fonti
Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201
Eli Lilly led a $100M equity round in Absci, investing $40M to advance ABS-201, the first AI-designed injectable antibody targeting hair loss and
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fortune.com
Eli Lilly just placed a $40 million bet on the next injectable boom | Fortune
The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.
- ·
cryptobriefing.com
Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201
Eli Lilly led a $100M equity round in Absci, investing $40M to advance ABS-201, the first AI-designed injectable antibody targeting hair loss and
- ·
cryptonomist.ch
anticorpo iniettabile progettato con ai: un investimento di eli lilly
L'anticorpo iniettabile progettato con ai di Eli Lilly potrebbe rivoluzionare i trattamenti per alopecia ed endometriosi.